Commentary: Systematic reviewers face challenges from varied study designs. by Altman, D

Donald Mainland: anatomist, educator, thinker, medical statistician, trialist, rheumatologist by Altman, D

Statistics in medical journals: some recent trends. by Altman, D

Systematic reviews of evaluations of prognostic variables. by Altman, D

Building a metaphor: another brick in the wall? by Altman, D

Moderate alcohol intake and cardiometabolic risk in adults with type 2 diabetes: To the editor by Altman, D

Assessing new methods of clinical measurement. by Altman, D

Quantifying the magnitude of baseline covariate imbalances resulting from selection bias in randomized clinical trials - Comment by Altman, D

Randomisation in the SYMPHONY trial. by Altman, D

Statistics in medical journals: some recent trends by Altman, D

False reassurance based on non-significant results by Altman, D

Systematic reviews of evaluations of prognostic variables. by Altman, D

A meta-analysis of hormone replacement therapy for fracture prevention. by Altman, D

Poor-quality medical research: what can journals do? by Altman, D

Prognostic models: a methodological framework and review of models for breast cancer. by Altman, D

New edicts for letters - Restrictions should not be imposed on post-publication peer review by Altman, D

Topics in and around higher-order Fourier analysis by Altman, D

Why we need confidence intervals. by Altman, D

Transparent reporting of trials is essential. by Altman, D

The time has come to register diagnostic and prognostic research. by Altman, D